Company Overview and News

26
Eldorado Gold: Know The Management Team

2018-10-08 seekingalpha - 2
Many investors look at their mining stocks with rose-colored glasses, unable to admit they may be in inferior companies.
ABX MUX.RTWI ELD KGI MUX KGI.DB.A KGI.DB MUX KL ABX EGO

111
Miners I'm Buying And Why - Part X: FOMO Speculation Vs. Cheap Resource Value; A Baker's Half Dozen Set To Rise - Small-Cap Stock Observer

2018-10-01 seekingalpha - 7
Science and art, or if you prefer skill and luck, are both needed for consistent success in short-term trading to long-term investing. Some deny this and say it's all math, claiming that markets always represent fair value. If so, high-frequency trading algo-bot scalpers will always win, meaning people can never outsmart to beat the market as all opportunities and risks are fully discounted into prices.
STZ.B TWX MEAOF BTR AMZN AABA LVNSF FQM NDM MISVF HVBTF GDX AXXDF STZ TWC PRU SLV BABA ATUSF AAUKF VZ BALMF BB FB DB KGI.DB NFLX GOOG GLD TLRY ALS WEED NAK PMNXF AAPL FQVLF PRU ADV BLKCF DIS KL GDXJ EGO FM KGI MSV KGI.DB.A AAL CGC NDMWF ELD BAR NGLOY

47
EGO / Eldorado Gold Corporation 6-K (Current Report of Foreign Issuer)

2018-10-01 sec.gov - 24
JA Filed by Filing Services Canada Inc. 403-717-3898
EGO

29
AngloGold Ashanti: Moves By New CEO Will Dictate Long-Term Fate

2018-09-25 seekingalpha - 1
There might be more to come, but the market will likely wait for the moves of the newly appointed CEO.
HMY ABX NEM YRI ABGLF AU K GDX AULGF ABGLY ELD KGC AUY ACA AEM AGG HGMCF EGO ABX

33
Resource Sector Digest: New Gold Cleaning The Slate, Again

2018-09-25 seekingalpha - 1
Another CEO is having a shot at fixing New Gold. Unfortunately, things have gone from bad to worse since the last iteration on this theme. Welcome to this week's
OCANF CAT IVN LIACF TMMFF NGD NSU BTR AMGGF IAG IPMLF ABX III NGD GPL OKSWF EQXGF RGLD ATUSF MNIKF AMLM OSKGF VTT RGL HRT VDTAF HRTFF BDREF CGOOF KGI.DB NGDAF CG VITFF TREVF AGI CAGDF OR RIC CSFFF CS KL CORVF EGO RIC ABX KOR KGI KGI.DB.A AGI BDR VIT IVPAF TMR ELD

26
Lessons From A Market Great: Randy McKay

2018-09-24 seekingalpha - 1
Randy McKay was an enormously successful trader who started his trading career by turning $2,000 into $70,000 in the newly formed currency futures market.
ABX ELD AUY YRI PAAS NFLX EGO ABX

31
Iamgold: Looking At Rebound Potential

2018-09-20 seekingalpha - 1
IAMGOLD shares will likely be sensitive to the gold price and look like a good momentum buy if gold prices finally have upside from the $1,200 level.
HMY ABX NEM YRI K ELD KGC AUY AEM IAG HGMCF EGO ABX

27
Harmony Gold Mining Stock Showing Strength Amid Weaker Gold Prices

2018-09-20 seekingalpha
Back in June, I wrote an update on Harmony Gold Mining (HMY) following the company's equity raise near yearly lows. Currently, I'm intrigued by the possibility of a rebound in gold mining stocks as gold tries to get some upside from the $1,200 level (I've already laid out my views on Barrick Gold (ABX) (here), Agnico Eagle Mines (AEM) (here), Newmont Mining (NEM) (here), Yamana Gold (AUY) (here), Eldorado Gold (EGO) (here), Goldcorp (here), Kinross Gold (here)).
HMY ABX ELD KGC AUY NEM YRI K AEM HGMCF EGO ABX

23
NV Gold Appoints Peter A. Ball as President and COO

2018-09-20 globenewswire
VANCOUVER, British Columbia, Sept. 20, 2018 (GLOBE NEWSWIRE) -- NV Gold Corporation (TSX.V: NVX; OTC Pink: NVGLF) (“NV Gold” or the “Company”) announces that it has appointed Mr. Peter A. Ball as its President and COO. Mr. Ball has been a director of NV Gold since September 29, 2016 and will continue as a director. John Watson, NV Gold’s former President and CEO and a director, will continue as a director and officer of the Company in the role of Chairman and CEO.
RGCTF NVX CBGDF RGC ANARF ELD ADI AGXMF NVGLF EGO

23
Eldorado Gold: Is The Greek Government Acting Above The Law? So It Seems (Update)

2018-09-19 seekingalpha
Hellas Gold S.A. has filed a non-judicial request for payment of approximately €750 million with the Hellenic Republic, arising from delays in the issuance of permits for the Skouries project.
ICGQF ICG ELD OUKPF EGO

23
Eldorado Gold Wants 750 Million Euros From Greece

2018-09-18 seekingalpha
Eldorado Gold asks Greece to pay 750 million euros for its misfortunes with the Skouries project.
ELD EGO

24
EGO / Eldorado Gold Corporation FORM 6-K (Current Report of Foreign Issuer)

2018-09-18 sec.gov - 1
JA Filed by Filing Services Canada Inc. 403-717-3898
EGO

23
CANADA STOCKS-TSX edges higher as energy shares gain on rising oil prices

2018-09-18 reuters
Sept 18 (Reuters) - Canada’s main stock index edged higher on Tuesday, boosted by gains in energy companies as oil prices rose on signs that OPEC may not raise output to address shrinking supplies from Iran.
NGD ELD NGDAF FQVLF FQM NGD EGO

23
Eldorado Gold seeks $877 mln compensation from Greece for permit delays

2018-09-18 reuters
(Reuters) - Eldorado Gold said on Tuesday it would seek a compensation of 750 million euros ($877.35 million)from Greece for damages suffered by the Canadian miner due to delays in the issuance of permits for its Skouries project.
ELD EGO

23
Canadian gold mine owner seeks damages from Greece

2018-09-18 nzherald.co.nz
ATHENS, Greece (AP) — Canadian gold mining firm Eldorado Gold is seeking 750 million euros ($875 million) in damages from the Greek state over delays in permits for mining work in the north of the country.
ELD EGO

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to EGO / Eldorado Gold Corporation on message board site Silicon Investor.

The Ego Forum The Ego Forum The Ego Forum OncoSecu0027s New Arsenal in the Cancer War- UT San Diego OncoSecu0027s New Arsenal in the Cancer War- UT San Diego OncoSecu0027s New Arsenal in the Cancer War- UT San Diego
National Information Consortium Inc (EGOV) National Information Consortium Inc (EGOV) National Information Consortium Inc (EGOV) EGOC check out there new technology and patent EGOC check out there new technology and patent EGOC check out there new technology and patent
International Freegold *** Seriously Undervalued??? International Freegold *** Seriously Undervalued??? International Freegold *** Seriously Undervalued??? Intu0027l Freegold Mineral Development Inc./ITF/VSE Intu0027l Freegold Mineral Development Inc./ITF/VSE Intu0027l Freegold Mineral Development Inc./ITF/VSE
FREEGOLD VENTURES LTD (Bulls Board) FREEGOLD VENTURES LTD (Bulls Board) FREEGOLD VENTURES LTD (Bulls Board) THE San Diego Padres and Chargers board THE San Diego Padres and Chargers board THE San Diego Padres and Chargers board
Megola Environmental Services Megola Environmental Services Megola Environmental Services FUGO - Fuego Entertainment, Inc. FUGO - Fuego Entertainment, Inc. FUGO - Fuego Entertainment, Inc.
CUSIP: 284902103